Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Public Health ; 236: 436-440, 2024 Sep 20.
Artigo em Inglês | MEDLINE | ID: mdl-39305662

RESUMO

OBJECTIVES: To increase organ donation rates, many countries have switched from an opt-in ('explicit consent') default for organ donation to an opt-out ('presumed consent') default. This study sought to determine the extent to which this change in default has led to an increase in the number of deceased individuals who become organ donors. STUDY DESIGN: Longitudinal retrospective analysis. METHODS: We conducted a retrospective analysis of within-country longitudinal data to assess the effect of changing the organ donation default policy from opt-in to opt-out. Our analysis focused on the longitudinal deceased donor rates in five countries (Argentina, Chile, Sweden, Uruguay, Wales) that had adopted this change. Using a Bayesian aggregated binomial regression model, we estimated the odds of organ donation within each country over time, as well as the effect of the policy switch. RESULTS: Switching from an opt-in to an opt-out default did not result in an increase in donation rates when averaged across countries. Moreover, the opt-out default did not lead to even a gradual increase in donations: there was no discernible difference in the linear rate of change of donations after the change in default. Finally, the COVID-19 pandemic was associated with a reduction in the odds of donation across all five countries. CONCLUSIONS: Our longitudinal analysis suggests that changing to an opt-out default does not increase organ donation rates. Unless flanked by investments in healthcare, public awareness campaigns, and efforts to address the concerns of the deceased's relatives, a shift to an opt-out default is unlikely to increase organ donations.

2.
Obes Rev ; 19(5): 638-653, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29334693

RESUMO

Findings on the relationship between family meal frequency and children's nutritional health are inconsistent. The reasons for these mixed results have to date remained largely unexplored. This systematic review and meta-analysis of 57 studies (203,706 participants) examines (i) the relationship between family meal frequency and various nutritional health outcomes and (ii) two potential explanations for the inconsistent findings: sociodemographic characteristics and mealtime characteristics. Separate meta-analyses revealed significant associations between higher family meal frequency and better overall diet quality (r = 0.13), more healthy diet (r = 0.10), less unhealthy diet (r = -0.04) and lower body mass index, BMI (r = -0.05). Child's age, country, number of family members present at meals and meal type (i.e. breakfast, lunch or dinner) did not moderate the relationship of meal frequency with healthy diet, unhealthy diet or BMI. Socioeconomic status only moderated the relationship with BMI. The findings show a significant relationship between frequent family meals and better nutritional health - in younger and older children, across countries and socioeconomic groups, and for meals taken with the whole family vs. one parent. Building on these findings, research can now target the causal direction of the relationship between family meal frequency and nutritional health.


Assuntos
Comportamento Alimentar/fisiologia , Refeições , Valor Nutritivo/fisiologia , Obesidade Infantil/prevenção & controle , Índice de Massa Corporal , Criança , Fenômenos Fisiológicos da Nutrição Infantil , Família , Humanos , Pais/educação , Obesidade Infantil/epidemiologia , Fatores Socioeconômicos , Fatores de Tempo
3.
Pathologe ; 30(4): 292-301, 2009 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-19495763

RESUMO

Malignant mixed Mullerian tumors (MMMT; carcinosarcomas) are rare epithelial-mesenchymal tumors. With an overall survival rate of 30%-40% the prognosis is much worse compared to high grade endometrioid or serous/clear cell carcinomas. Depending on the histology of the mensenchymal components a distinction is made between homologous and heterologous MMMT. Clinical, morphologic and molecular data suggest that MMMTs are really metaplastic carcinomas in which the mesenchymal part retains epithelial features. The strongest prognostic factor is tumor stage followed by lymph node metastases, deep myometrial infiltration, involvement of the cervix and tumor size. The distinction between homologous and heterologous MMMT is prognostically insignificant. Due to unreliable clinical staging and a high rate of occult lymph node metastases, the pathological-anatomical work-up is of great importance. Clinical and pathologic staging should be performed as in endometrial carcinoma. The main differential diagnoses include uterine sarcomas, adenosarcoma and benign metaplastic change within the endometrium.


Assuntos
Carcinossarcoma/patologia , Neoplasias Uterinas/patologia , Carcinoma Endometrioide/patologia , Carcinossarcoma/mortalidade , Carcinossarcoma/radioterapia , Colo do Útero/patologia , Feminino , Humanos , Imuno-Histoquímica/métodos , Metástase Linfática , Miométrio/patologia , Estadiamento de Neoplasias , Prognóstico , Taxa de Sobrevida , Neoplasias do Colo do Útero/patologia , Neoplasias do Colo do Útero/radioterapia , Neoplasias Uterinas/mortalidade , Neoplasias Uterinas/radioterapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA